Plandai Biotechnology (PLPL) Stock Statistics & Valuation Metrics
Total Valuation
Plandai Biotechnology has a market cap or net worth of $44.89K. The enterprise value is $448.89B.
- Market Cap
- $44.89K
- Enterprise Value
- $448.89B
Share Statistics
Plandai Biotechnology has 44,889,535,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 44,889,535,000
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Plandai Biotechnology’s return on equity (ROE) is -291.44 and return on invested capital (ROIC) is -3811.00%.
- Return on Equity (ROE)
- -291.44
- Return on Assets (ROA)
- 160.29
- Return on Invested Capital (ROIC)
- -3811.00%
- Return on Capital Employed (ROCE)
- -84.69
- Revenue Per Employee
- 0
- Profits Per Employee
- 89.05K
- Employee Count
- 180
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Plandai Biotechnology is -87.33. Plandai Biotechnology’s PEG ratio is -0.87.
- PE Ratio
- -87.33
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.87
Income Statement
In the last 12 months, Plandai Biotechnology had revenue of 0 and earned 16.03M in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -3.81M
- Pretax Income
- 16.03M
- Net Income
- 16.03M
- EBITDA
- 35.88M
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was 15.81M and capital expenditures -3, giving a free cash flow of 15.81M billion.
- Operating Cash Flow
- 15.81M
- Free Cash Flow
- 15.81M
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Plandai Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -1.15%
Stock Price Statistics
- Beta
- -95.63
- 52-Week Price Change
- -99.33%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Plandai Biotechnology as a current ratio of 0.00, with Debt / Equity ratio of -281.82%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- -841.28
Taxes
In the past 12 months, Plandai Biotechnology has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Plandai Biotechnology EV to EBITDA ratio is -87.33, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- -87.33
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Plandai Biotechnology has $0.00 in cash and marketable securities with $155.00K in debt, giving a net cash position of -$155.00K billion.
- Cash & Marketable Securities
- $0.00
- Total Debt
- $155.00K
- Net Cash
- -$155.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Plandai Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
